Neobe raises $6.8 million to enhance cancer treatment efficacy. The funding will support their development of engineered bacteria to overcome treatment barriers.
Amount Raised
$6.8 Million
Round Type
Venture
EnglandBiotechnologyHealth CareDescription
Neobe, a UK biotech startup, has successfully raised $6.8 million in a recent funding round. The capital will be used to further develop engineered bacteria designed to address barriers preventing cancer treatments from being effective. This innovation aims to improve the outcomes for cancer patients. The investment highlights growing interest in novel biotech solutions in the healthcare industry.
Who to call at Neobe, and when
A new round usually means Neobe is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Neobe raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Neobe, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Neobe. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Neobe raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Neobe raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.